RSC Advances
Paper
1026, 896, 855, 750; 1H NMR (300 MHz, 26 mg: 0.4 mL CDCl3): d mmol, 71% yield) of pure o-methoxy-a-nitroisobutyranilide (26)
1.98 (6H, s, CH3), d 7.04 (1H, td, ArH4, J 2, J 8), d 7.34 (1H, td, as tiny, pretty, orange prisms or various morphology, m.p. 67–
ArH5, J 2, J 8), d 7.56 (1H, dd, ArH3, J 2, J 8), d 8.24 (1H, dd, ArH6, J 70 ꢂC; Rf ¼ 0.40 in 4 : 1 hexanes/EtOAc, 0.65 in 65 : 35 hexanes/
2, J 8), d 8.52 (1H, br, s, NH); 13C NMR (75 MHz, 66 mg: 0.4 mL EtOAc and 0.89 in 1 : 1 hexanes/EtOAc; IR(cmꢀ1): 3331, 3043,
CDCl3): d 24.9 (s, C-3A/B), d 91.4 (s, C-2), d 114.8 (s, C-20), d 122.6 3005, 2964, 2936, 2901, 2838, 1675 (C]O), 1594, 1553, 1521,
(s, C-60), d 126.8 (s, C-50), d 128.9 (s, C-30), d 132.8 (s, C-40), d 134.9 1493, 1460, 1432, 1403, 1375, 1357, 1322, 1287, 1262, 1220,
(s, C-10), d 164.9 (s, C-1); GC-(EI) TOF-HRMS: calcd m/z for 1177, 1142, 1112, 1042, 1025, 963, 899, 862, 849, 780, 748, 739,
C
10H11N2O3Br: 285.9953, observed: 285.9961.
o-Chloro-a-nitroisobutyranilide (20). 19 (o-Chloro-a-bro- s, CH3), d 3.91 (3H, s, O–CH3), d 6.90 (1H, dd, ArH3, J 2, J 8), d
724, 666; 1H NMR (300 MHz, 19 mg: 0.4 mL CDCl3): d 1.95 (6H,
moisobutyranilide) (1.38 g, 4.99 mmol) gave 955 mg (3.94 6.97 (1H, td, ArH5, J 2, J 8), d 7.10 (1H, td, ArH4, J 2, J 8), d 8.28
mmol, 79% yield) of pure o-chloro-a-nitroisobutyranilide (20) as (1H, dd, ArH6, J 2, J 8), d 8.62 (1H, br, s, NH); 13C NMR (75 MHz,
an amber oil; Rf ¼ 0.43 in 4 : 1 hexanes/EtOAc, 0.70 in 65 : 35 57 mg: 0.4 mL CDCl3): d 24.9 (s, C-3A/B), d 56.2 (s, O–CH3), d 91.6
hexanes/EtOAc and 0.90 in 1 : 1 hexanes/EtOAc; IR(cmꢀ1): 3352, (s, C-2), d 110.4 (s, C-30), d 120.3 (s, C-60), d 121.4 (s, C-50), d 125.3
2998, 2922, 2852, 1697 (C]O), 1594, 1549, 1518, 1467, 1441, (s, C-40), d 126.9 (s, C-10), d 148.7 (s, C-20), d 164.4 (s, C-1); GC-(EI)
1398, 1373, 1347, 1302, 1238, 1168, 1144, 1128, 1055, 1035, 897, TOF-HRMS: calcd m/z for C11H14N2O4: 238.0954, observed:
856, 751, 690; 1H NMR (300 MHz, 21 mg: 0.4 mL CDCl3): d 1.97 238.0952.
(6H, s, CH3), d 7.11 (1H, td, ArH4, J 2, J 8), d 7.30 (1H, td, ArH5, J
m-Methoxy-a-nitroisobutyranilide (28). 27 (m-Methoxy-a-
2, J 8), d 7.40 (1H, dd, ArH3, J 2, J 8), d 8.26 (1H, dd, ArH6, J 2, J 8), bromoisobutyranilide) (1.40 g, 5.15 mmol) gave 981 mg (4.12
d 8.58 (1H, br, s, NH); 13C NMR (75 MHz, 39 mg: 0.4 mL CDCl3): mmol, 80% yield) of pure m-methoxy-a-nitroisobutyranilide (28)
d 24.9 (s, C-3A/B), d 91.5 (s, C-2), d 122.2 (s, C-60), d 124.2 (s, C-20), d as a crystalline mass of orange tipped needles, m.p. 97–99 ꢂC; Rf
126.2 (s, C-50), d 128.2 (s, C-30), d 129.5 (s, C-40), d 133.8 (s, C-10), d ¼ 0.29 in 4 : 1 hexanes/EtOAc, 0.55 in 65 : 35 hexanes/EtOAc
164.7 (s, C-1); GC-(EI) TOF-HRMS: calcd m/z for C10H11N2O3Cl: and 0.85 in 1 : 1 hexanes/EtOAc; IR(cmꢀ1): 3276, 3223, 3154,
242.0458, observed: 242.0462.
3007, 2943, 2838, 1665 (C]O), 1614, 1597, 1539, 1489, 1451,
m-Chloro-a-nitroisobutyranilide (22). 21 (m-Chloro-a-bro- 1427, 1397, 1373, 1344, 1320, 1301, 1277, 1267, 1208, 1182,
moisobutyranilide) (1.38 g, 4.99 mmol) gave 1135 mg (4.68 1149, 1031, 953, 844, 788, 764, 749, 727, 686; 1H NMR (300 MHz,
mmol, 94% yield) of pure m-chloro-a-nitroisobutyranilide (22) 28 mg: 0.4 mL CDCl3): d 1.93 (6H, s, CH3), d 3.80 (3H, s, O–CH3),
as a light orange crystalline mass with multiple nucleation d 6.72 (1H, dd, ArH4, J 2, J 8), d 6.96 (1H, dd, ArH6, J 2, J 8), d 7.22
points, m.p. 125–128 ꢂC; Rf ¼ 0.47 in 4 : 1 hexanes/EtOAc, 0.72 (1H, t, ArH5, J 8), d 7.26 (1H, d, ArH2, J 2), d 7.98 (1H, br, s, NH);
in 65 : 35 hexanes/EtOAc and 0.89 in 1 : 1 hexanes/EtOAc; 13C NMR (75 MHz, 120 mg: 0.4 mL CDCl3): d 24.6 (s, C-3A/B), d
IR(cmꢀ1): 3385, 3188, 3122, 3071, 2988, 2941, 2895, 1656 (C] 55.5 (s, O–CH3), d 91.5 (s, C-2), d 106.8 (s, C-60), d 111.6 (s, C-20), d
O), 1590, 1552, 1528, 1478, 1459, 1418, 1398, 1372, 1351, 1304, 113.2 (s, C-40), d 130.0 (s, C-50), d 138.0 (s, C-10), d 160.4 (s, C-30), d
1287, 1254, 1240, 1231, 1187, 1142, 1092, 1074, 999, 914, 904, 165.2 (s, C-1); GC-(EI) TOF-HRMS: calcd m/z for C11H14N2O4:
888, 854, 791, 704, 682; 1H NMR (300 MHz, 18 mg: 0.4 mL 238.0954, observed: 238.0954.
CDCl3): d 1.82 (6H, s, CH3), d 6.99 (1H, d, ArH4, J 8), d 7.14 (1H,
p-Methoxy-a-nitroisobutyranilide (30). 29 (p-Methoxy-a-bro-
td, ArH5, J 2, J 8), d 7.43 (1H, d, ArH6, J 8), d 7.64 (1H, m, ArH2), d moisobutyranilide) (1.40 g, 5.15 mmol) gave 1078 mg (4.53
9.38 (1H, br, s, NH); 13C NMR (75 MHz, 18 mg: 0.4 mL CDCl3/2 mmol, 77% yield) of pure p-methoxy-a-nitroisobutyranilide (30)
drops d6-DMSO): d 24.7 (s, C-3A/B), d 91.2 (s, C-2), d 118.9 (s, C-60), as tiny, pretty, pale yellow needles, m.p. 69–71 C; Rf ¼ 0.16 in
ꢂ
d 121.0 (s, C-20), d 124.7 (s, C-40), d 129.8 (s, C-50), d 134.2 (s, C-30), 4 : 1 hexanes/EtOAc, 0.48 in 65 : 35 hexanes/EtOAc and 0.80 in
d 139.3 (s, C-10), d 165.8 (s, C-1); GC-(EI) TOF-HRMS: calcd m/z 1 : 1 hexanes/EtOAc; IR(cmꢀ1): 3346, 3003, 2961, 2939, 2898,
for C10H11N2O3Cl: 242.0458, observed: 242.0475.
2840, 1660 (C]O), 1597, 1545, 1530, 1510, 1462, 1440, 1414,
p-Chloro-a-nitroisobutyranilide (24). 23 (p-Chloro-a-bro- 1403, 1375, 1356, 1311, 1299, 1268, 1232, 1184, 1173, 1141,
moisobutyranilide) (1.38 g, 4.99 mmol) gave 1070 mg (4.41 1112, 1031, 962, 901, 863, 850, 824, 764; 1H NMR (300 MHz, 28
mmol, 88% yield) of pure p-chloro-a-nitroisobutyranilide (24) as mg: 0.4 mL CDCl3): d 1.92 (6H, s, CH3), d 3.79 (3H, s, O–CH3), d
a pale yellow, clean looking crystalline powder, m.p. 124–127 ꢂC; 6.86 (2H, d, ArH3, J 8), d 7.37 (2H, d, ArH2, J 8), d 7.87 (1H, br, s,
Rf ¼ 0.38 in 4 : 1 hexanes/EtOAc, 0.67 in 65 : 35 hexanes/EtOAc NH); 13C NMR (75 MHz, 120 mg: 0.4 mL CDCl3): d 24.9 (s, C-3A/
and 0.90 in 1 : 1 hexanes/EtOAc; IR(cmꢀ1): 3303, 3195, 3126, B), d 55.8 (s, O–CH3), d 91.5 (s, C-2), d 114.5 (s, C-30), d 122.9 (s, C-
3057, 3002, 2924, 2854, 1664 (C]O), 1599, 1547, 1533, 1492, 20), d 129.8 (s, C-10), d 157.5 (s, C-40), d 164.9 (s, C-1); GC-(EI) TOF-
1460, 1400, 1379, 1353, 1308, 1287, 1241, 1188, 1145, 1087, HRMS: calcd m/z for C11H14N2O4: 238.0954, observed: 238.0971.
1014, 960, 904, 864, 820, 747, 708, 695, 667; 1H NMR (300 MHz,
N-Benzyl-a-nitroisobutyramide (32). 31 (N-Benzyl-a-bromoi-
21 mg: 0.4 mL CDCl3): d 1.94 (6H, s, CH3), d 7.30 (2H, d, ArH3, J sobutyramide) (1.40 g, 5.47 mmol) was added to NaNO2 and
8), d 7.44 (2H, d, ArH2, J 8), d 8.01 (1H, br, s, NH); 13C NMR (75 DMF and the reaction heated at 120 ꢂC for 4 h. Aer cooling the
MHz, 21 mg: 0.4 mL CDCl3): d 25.0 (s, C-3A/B), d 91.7 (s, C-2), d standard workup method gave 952 mg (4.29 mmol, 78% yield)
122.3 (s, C-20), d 129.5 (s, C-30), d 131.0 (s, C-40), d 135.5 (s, C-10), d of pure N-benzyl-a-nitroisobutyramide (32) as white, crystalline,
164.8 (s, C-1); GC-(EI) TOF-HRMS: calcd m/z for C10H11N2O3Cl: cauliower-shaped nodules, m.p. 87–88 ꢂC; Rf ¼ 0.23 in 4 : 1
242.0458, observed: 242.0477.
hexanes/EtOAc, 0.49 in 65 : 35 hexanes/EtOAc and 0.76 in 1 : 1
o-Methoxy-a-nitroisobutyranilide (26). 25 (o-Methoxy-a-bro- hexanes/EtOAc; IR(cmꢀ1): 3295, 3088, 3028, 3003, 2930, 1652
moisobutyranilide) (1.40 g, 5.15 mmol) gave 868 mg (3.65 (C]O), 1547, 1496, 1453, 1427, 1405, 1374, 1356, 1312, 1288,
76414 | RSC Adv., 2015, 5, 76401–76418
This journal is © The Royal Society of Chemistry 2015